| Notes forming part of accounts [line items] | | |
| Disclosure of notes and other explanatory information [text block] | | |
| Disclosure of general information about reporting entity [abstract] | | |
| Disclosure of basis of preparation of financial statements [text block] |
BASIS OF PREPARATION
(a) Statement of compliance
The interim condensed financial statements of the Company as at and for the period ended 31 March 2020 have been prepared in accordance with International Accounting Standard 34 Interim Financial Reporting (“IAS 34”) as endorsed in the Kingdom of Saudi Arabia.
The financial statements of the Company as at and for the period ended 31 March 2019, respectively, were prepared in compliance with the IAS 34 and the International Financial Reporting Standards (“IFRS”) respectively, as modified by SAMA for the accounting of zakat and income tax (relating to the application of IAS 12 – “Income Taxes” and IFRIC 21 – “Levies” so far as these relate to zakat and income tax) and the Regulations for Companies in the Kingdom of Saudi Arabia.
On 23 July 2019, SAMA instructed the insurance companies in the Kingdom of Saudi Arabia to account for the zakat and income taxes in the statement of income. This aligns with the IFRS and its interpretations as issued by the International Accounting Standards Board (“IASB”) and as endorsed in the Kingdom of Saudi Arabia.
Accordingly, the Company changed its accounting treatment for zakat and income tax by retrospectively adjusting the impact in line with International Accounting Standard 8 Accounting Policies, Changes in Accounting Estimates and Errors (as disclosed in note 3) and the effects of this change are below;
Financial statement impact | Account | Balance as previously reported as at / for the period ended 31 March 2019 | Effect of restatement | Balance as restated as at / for the period ended 31 March 2019 | Statement of changes in equity | Zakat and income tax | 983 | (983) | - | Statement of income | Zakat charge for the period | - | 983 | 983 | Statement of income | Earnings per share | 0.10 | (0.04) | 0.06 |
2. BASIS OF PREPARATION-(Continued)
(a) Statement of compliance-(Continued)
These interim condensed financial statements are prepared under the going concern basis and the historical cost convention, except for the measurement at fair value of available-for-sale investments. The Company’s statement of financial position is not presented using a current/non-current classification. However, the following balances would generally be classified as current: cash and cash equivalents, term deposits, premiums and reinsurers’ receivable - net, reinsurers’ share of unearned premium, reinsurers’ share of outstanding claims, reinsurers’ share of claims incurred but not reported, deferred policy acquisitions cost, due from related parties, prepaid expenses and other assets, policyholders claim payable, accrued and other liabilities, unearned premiums, unearned reinsurance commission, outstanding claims, claims incurred but not reported, other technical reserves, surplus distribution payable and zakat and income tax. The following balances would generally be classified as non-current: end-of-service indemnities, investments, statutory deposit, accrued income on statutory deposit and property and equipment.
The Company presents its statement of financial position in order of liquidity. As required by the Saudi Arabian Insurance Regulations, the Company maintains separate books of accounts for Insurance Operations and Shareholders’ Operations and presents the financial statements accordingly (note 18). Assets, liabilities, revenues and expenses clearly attributable to either activity are recorded in the respective accounts. The basis of allocation of expenses from joint operations is determined and approved by the management and the Board of Directors.
The interim condensed statement of financial position, statements of income, comprehensive income and cash flows of the insurance operations and shareholders’ operations which are presented in Note 18 of the interim condensed financial statements have been provided as supplementary financial information to comply with the requirements of the guidelines issued by SAMA implementing regulations and is not required under IFRSs. SAMA implementing regulations requires the clear segregation of the assets, liabilities, income and expenses of the insurance operations and the shareholders’ operations. Accordingly, the statements of financial position, statements of income, comprehensive income and cash flows prepared for the insurance operations and shareholders operations as referred to above, reflect only the assets, liabilities, income, expenses and comprehensive gains or losses of the respective operations.
In preparing the Company-level interim condensed financial statements in compliance with IFRS, the balances and transactions of the insurance operations are amalgamated and combined with those of the shareholders’ operations. Inter-operation balances, transactions and unrealised gains or losses, if any, are eliminated in full during amalgamation. The accounting policies adopted for the insurance operations and shareholders’ operations are uniform for like transactions and events in similar circumstances.
The inclusion of separate information of the insurance operations with the financial information of the Company in the statement of financial position, the statement of income, statement of comprehensive income, cash flows as well as certain relevant notes to the financial information represents additional supplementary information required as required by the implementing regulations.
2. BASIS OF PREPARATION-(Continued)
(a) Statement of compliance-(Continued)
As per the by-laws of the Company, surplus arising from the Insurance Operations is distributed as follows:
Transfer to Shareholders’ operations | 90% | Transfer to Policyholders’ operations | 10% |
| 100% |
In case of deficit, the whole deficit will be transferred to Shareholders’ operations.
(c) Functional and presentation currency
These interim condensed financial statements have been presented in Saudi Arabian Riyals (SAR), which is also the functional currency of the Company. All financial information presented in Saudi Arabian Riyal has been rounded to the nearest thousands, except where otherwise indicated.
(d) Fiscal year
The Company follows a fiscal year ending December 31.
(e) Significant accounting estimates and judgements
The preparation of condensed interim financial statements requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.
In preparing these condensed financial statements, the significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty including the risk management policies were the same as those that applied to the annual financial statements as at and for the year ended 31 December 2019. Further, the Company has considered the following:
On 11 March 2020, the World Health Organization (“WHO”) declared the Coronavirus (“Covid-19”) outbreak as a pandemic in recognition of its rapid spread across the globe. This outbreak has also affected the GCC region including the Kingdom of Saudi Arabia. Governments all over the world took steps to contain the spread of the virus. Saudi Arabia in particular has implemented closure of borders, released social distancing guidelines and enforced country-wide lockdowns and curfews.
In response to the spread of the Covid-19 virus in the GCC and other territories where the Company operates and its consequential disruption to the social and economic activities in those markets, the Company’s management has proactively assessed its impacts on its operations and has taken a series of proactive and preventative measures and processes to ensure:
Also refer subsequent event note 20 in relation to SAMA Circular 189 issued on 8 May 2020 in response to the Covid-19 pandemic
2. BASIS OF PREPARATION-(Continued)
(e) Significant accounting estimates and judgements
Impact of Covid-19 on the medical technical reserves and financial assets
Medical technical reserves
Notwithstanding these challenges, the Company’s management believes that the technical reserves for the medical line of business remain largely unaffected as the insurance industry isfacilitated by the Saudi Arabian Government initiative of bearing all costs associated with Covid-19 pandemic, which include testing and treatment costs. Moreover, there is a general decrease in trend in medical claims which are of a routine nature. Furthermore, the industry has not experienced a significantly high number of reported claims. Based on these factors, the Company’s management believes that the Covid-19 pandemic has had no material effects on Company’s reported results for the three-month period ended 31 March 2020. The Company’s management continues to monitor the situation closely.
Financial assets
The Company has performed an assessment in accordance with its accounting policy due to the Covid-19 pandemic to determine whether there is objective evidence that a financial asset or group of financial assets are impaired. These include factors such as, significant financial difficulties of issuers or debtors, default or delinquency in payments, probability that the issuer or debtor will enter bankruptcy or other financial reorganization, etc. In the case of equities classified under available-for-sale, the Company has performed an assessment to determine whether there is a significant decline in the fair value of financial assets below their cost. Based on these assessments, the Company’s management believes that the Covid-19 pandemic has had no material effects on Company’s reported results for the three-months period ended 31 March 2020. The Company’s management continues to monitor the situation closely.
Credit risk management
The Company has strengthened its credit risk management policies to address the fast changing and evolving risks posed by the current circumstances. These include review of credit concentrations at the granular economic sector, region and counterparty level and the Company has taken appropriate action where required. Based on the review, the Company has identified the certain sectors such as government contracting, airlines, retail sector and hospitality industry as being impacted significantly by the Covid-19 pandemic and lower oil prices. | 2 |
| Disclosure of other general disclosures about reporting entity [text block] | 1. ORGANIZATION AND PRINCIPAL ACTIVTIESAllied Cooperative Insurance Group (“the Company”) is a Saudi Joint Stock Company registered in the Kingdom of Saudi Arabia under Commercial Registration No. 4030171999 dated 9 Shabaan 1428H, corresponding to 22 August 2007. The activities of the Company are to transact cooperative insurance operations and related activities in the Kingdom of Saudi Arabia. On 4 April 2009, the Company received a license from the Saudi Arabian Monetary Authority (“SAMA”) to engage in insurance in Saudi Arabia. The Company commenced its commercial operations on 1 July 2009. The Company was listed on the Saudi Stock Exchange (Tadawul) on 27 August 2007. There are 3 registered branches as set out below:Branch Commercial Registration Number Place of issuance DateBranch of ACIG 2051043671 Al Khobar 12 Ramadan 1439 HBranch of ACIG 5855035150 Khamis Mushayt 12 Ramadan 1439 HBranch of ACIG 4030204059 Jeddah 12 Ramadan 1439 H | 1 |
| Disclosure of summary of significant accounting policies [abstract] | | |
| Description of changes in accounting policy [text block] |
SIGNIFICANT ACCOUNTING POLICIES
The accounting policies, estimates and assumptions used in the preparation of the interim condensed financial information are consistent with those followed in the preparation of the Company’s annual financial statements for the year ended 31 December 2019, except for the new standards and adoption of the amendments to existing standards which have had either insignificant effect or no financial impact on the interim condensed financial information of the Company on the current period or prior periods and are expected to have a insignificant effect in future period.
Change in accounting for zakat and income tax
As mentioned in note 2(a) above, the basis of preparation has been changed from the period ended 30 June 2019 as a result of the issuance of instructions from SAMA dated 23 July 2019. The Company has accounted for this change in the accounting for zakat and income tax retrospectively (see note 2(a) and the effects of the above change are also disclosed in note 2(a) to these interim condensed financial statements.
Standards issued but not yet effective
The Company has chosen not to early adopt the following new standards which have been issued but not yet effective for the Company’s accounting year beginning on 1 January 2020 and is currently assessing their impact.
SIGNIFICANT ACCOUNTING POLICIES-(Continued)
Standards issued but not yet effective-(Continued)
IFRS 17 - “Insurance Contracts”
Overview
This standard has been published in May, 2017. It establishes the principles for the recognition, measurement, presentation and disclosure of insurance contracts and supersedes IFRS 4 – Insurance contracts. The new standard applies to insurance contracts issued, to all reinsurance contracts and to investment contracts with discretionary participating features provided the entity also issues insurance contracts. It requires to separate the following components from insurance contracts: embedded derivatives, if they meet certain specified criteria; distinct investment components; and any promise to transfer distinct goods or non-insurance services.
These components should be accounted for separately in accordance with the related standards (IFRS 9 and IFRS 15).
Measurement In contrast to the requirements in IFRS 4, which permitted insurers to continue to use the accounting policies for measurement purposes that existed prior to January 2015, IFRS 17 provides the following different measurement models
The General Measurement Model (GMM) is based on the following “building blocks”:
a) the fulfilment cash flows (FCF), which comprise: probability-weighted estimates of future cash flows, an adjustment to reflect the time value of money (i.e. discounting) and the financial risks associated with those future cash flows, and a risk adjustment for non-financial risk;
b) the Contractual Service Margin (CSM). The CSM represents the unearned profit for a group of insurance contracts and will be recognized as the entity provides services in the future. The CSM cannot be negative at inception; any net negative amount of the fulfilment cash flows at inception will be recorded in profit or loss immediately. At the end of each subsequent reporting period the carrying amount of a group of insurance contracts is remeasured to be the sum of:
the liability for remaining coverage, which comprises the FCF related to future services and the CSM of the group at that date; and the liability for incurred claims, which is measured as the FCF related to past services allocated to the group at that date.
The CSM is adjusted subsequently for changes in cash flows related to future services. Since the CSM cannot be negative, changes in future cash flows that are greater than the remaining CSM are recognized in profit or loss.
The effect of changes in discount rates will be reported in either profit or loss or other comprehensive income, determined by an accounting policy choice.
The Variable Fee Approach (VFA) is a mandatory model for measuring contracts with direct participation features (also referred to as ‘direct participating contracts’). This assessment of whether the contract meets these criteria is made at inception of the contract and not reassessed subsequently. For these contracts, in addition to the adjustment under GMM, the CSM is also adjusted for:
the entity’s share of the changes in the fair value of underlying items, the effect of changes in the time value of money and in financial risks not relating to the underlying items.
SIGNIFICANT ACCOUNTING POLICIES-(Continued)
Standards issued but not yet effective-(Continued)
IFRS 17 - “Insurance Contracts” -(Continued)
In addition, a simplified Premium Allocation Approach (PAA) is permitted for the measurement of the liability for the remaining coverage if it provides a measurement that is not materially different from the General Model Measurement or if the coverage period for each contract in the group is one year or less. With the PAA, the liability for remaining coverage corresponds to premiums received at initial recognition less insurance acquisition cash flows. The General Measurement Model remains applicable for the measurement of the liability for incurred claims. However, the entity is not required to adjust future cash flows for the time value of money and the effect of financial risk if those cash flows are expected to be paid/received in one year or less from the date the claims are incurred.
Effective date
The IASB issued an Exposure Draft Amendments to IFRS 17 during June 2019 and received comments from various stakeholders. The IASB is currently re-deliberating issues raised by stakeholders. For any proposed amendments to IFRS 17, the IASB will follow its normal due process for standard-setting. The effective date of IFRS 17 and the deferral of the IFRS 9 temporary exemption in IFRS 4 is currently 1 January 2021. Under the current exposure draft, it is proposed to amend the IFRS 17 effective date to reporting periods beginning on or after 1 January 2023. This is a deferral of 1 year compared to the previous date of 1 January 2022. Earlier application is permitted if both IFRS 15 – Revenue from Contracts with Customers and IFRS 9 – Financial Instruments have also been applied. The Company intends to apply the Standard on its effective date
Transition
Retrospective application is required. However, if full retrospective application for a group of insurance contracts is impracticable, then the entity is required to choose either a modified retrospective approach or a fair value approach.
Presentation and Disclosures
The Company expects that the new standard will result in a change to the accounting policies for insurance contracts together with amendments to presentation and disclosures.
Impact: The Company is currently assessing the impact of the application and implementation of IFRS 17. As of 31 March 2020, the financial impact of adopting the standard has yet to be fully assessed by the Company. The Company has started with their implementation process and have set up an implementation committee. Further, the Company has undertaken a Gap Analysis and the key areas of Gaps are as follows:
Impact area |
| Summary of impact |
|
|
| Financial impact |
| Not yet fully assessed by the Company. |
|
|
| Data impact |
| The Company believes that the data impact is not likely to be significant as a major proportion of the company’s business would qualify for measurement under the premium allocation approach. |
|
|
| IT systems |
| The Company is already in the process of implementing a new upgraded IT system which will facilitate the implementation of IFRS 17 |
|
|
| Process impact |
| The process impact is under evaluation, but no significant process changes are anticipated. |
|
|
| Impact on reinsurance arrangements |
| The Company’s reinsurance arrangements are currently under testing to determine the suitable measurement approach |
|
|
| Impact on policies & control’s frameworks |
| The Company is currently working with an external consultant to review and modify the current policy control framework |
|
|
| Human resources |
| The Company needs to recruit suitably qualified personnel who have a comprehensive understanding of IFRS 17 |
SIGNIFICANT ACCOUNTING POLICIES-(Continued)
Standards issued but not yet effective-(Continued)
IFRS 9 - “Financial instruments”
This standard was published on 24 July 2014 and has replaced IAS 39. The new standard addresses the following items related to financial instruments.
a) Classification and measurement:
IFRS 9 uses a single approach to determine whether a financial asset is measured at amortized cost, at fair value through other comprehensive income or at fair value through profit or loss. A financial asset is measured at amortized cost if both: the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows; and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding (“SPPI”). The financial asset is measured at fair value through other comprehensive income and realized gains or losses are recycled through profit or loss upon sale, if both conditions are met: the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows and for sale; and the contractual terms of cash flows are SPPI,
Assets not meeting either of these categories are measured at fair value through profit or loss. Additionally, at initial recognition, an entity can use the option to designate a financial asset at fair value through profit or loss if doing so eliminates or significantly reduces an accounting mismatch.
For equity instruments that are not held for trading, an entity can also make an irrevocable election to present in other comprehensive income subsequent changes in the fair value of the instruments (including realized gains and losses), dividends being recognized in profit or loss. Additionally, for financial liabilities that are designated as at fair value through profit or loss, the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is recognized in other comprehensive income, unless the recognition of the effects of changes in the liability’s credit risk in other comprehensive income would create or enlarge an accounting mismatch in profit or loss.
b) Impairment:
The impairment model under IFRS 9 reflects expected credit losses, as opposed to incurred credit losses under IAS 39. Under the IFRS 9 approach, it is no longer necessary for a credit event to have occurred before credit losses are recognized. Instead, an entity always accounts for expected credit losses and changes in those expected credit losses. The amount of expected credit losses is updated at each reporting date to reflect changes in credit risk since initial recognition.
c) Hedge accounting:
IFRS 9 introduces new requirements for hedge accounting that align hedge accounting more closely with Risk Management. The requirements establish a more principles-based approach to the general hedge accounting model. The amendments apply to all hedge accounting with the exception of portfolio fair value hedges of interest rate risk (commonly referred to as “fair value macro hedges”). For these, an entity may continue to apply the hedge accounting requirements currently in IAS 39. This exception was granted largely because the IASB is addressing macro hedge accounting as a separate project.
SIGNIFICANT ACCOUNTING POLICIES-(Continued)
Standards issued but not yet effective-(Continued)
IFRS 9 - “Financial instruments”-(Continued)
Effective date
The published effective date of IFRS 9 was 1st January 2018. However, amendments to IFRS 4 – Insurance Contracts: Applying IFRS 9 – Financial Instruments with IFRS 4 – Insurance Contracts, published on 12 September 2016, changes the existing IFRS 4 to allow entities issuing insurance contracts within the scope of IFRS 4 to mitigate certain effects of applying IFRS 9 before the IASB’s new insurance contract standard (IFRS 17 – Insurance Contracts) becomes effective. The amendments introduce two alternative options:
the effective date of a new insurance contract standard; or annual reporting periods beginning on or after 1 January 2021. The IASB is proposing to extend the effective date of IFRS 17 and the IFRS 9 temporary exemption in IFRS 4 to 1 January 2022. Additional disclosures related to financial assets are required during the deferral period. This option is only available to entities whose activities are predominately connected with insurance and have not applied IFRS 9 previously; or
Adopt IFRS 9 but, for designated financial assets, remove from profit or loss the effects of some of the accounting mismatches that may occur before the new insurance contract standard is implemented. During the interim period, additional disclosures are required.
| 3 |
| Disclosure of notes forming part of accounts [abstract] | | |
| Disclosure of property and equipment [text block] | 9. RIGHT OF USE ASSETS, NET Building Total Total 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000 SR’000Cost: Impact of adoption of IFRS 16 7,227 7,227 9,985As at end of period / year 7,227 7,227 9,985 Accumulated amortization January 1 -Charge for the period (635) (635) (2,758)As at end of period / year (635) (635) (2,758) Net book value March 31, 2020 6,592 6,592 -December 31, 2019 - - 7,22710. LEASE LIABILITIES Building Total Total 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000 SR’000Liability At beginning of the period / year 7,122 7,122 -Impact of adoption of IFRS 16 - - 9,985Finance cost 62 62 321At end of the period / year 7,184 7,184 10,306 Payments At beginning of the period / year - - -Paid during period / year (1,121) (1,121) (3,184)At end of the period / year 6,063 6,063 7,122 | 9 |
| Disclosure of investments in available-for-sale investments [text block] | 7. AVAAILABLE-FOR-SALE INVESTMENTi) Shareholders’ operations Investments of the shareholders’ operations comprise the following:a) Investment securities are classified as follows: 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Investment in sukuk 25,000 25,000Quoted securities 9,628 11,256Unquoted securities 1,923 1,923 Units in quoted local real estate fund 11,449 12,927Total 48,000 51,106i) Available-for-sale investmentsMovements in available-for-sale investments are as follows: Investment in sukuk Quoted securities Unquoted Securities Units in quoted local real estate fund Total SR’000 SR’000 SR’000 SR’000 SR’000As at 1 January 2020 25,000 11,256 1,923 12,927 51,106Changes in fair value of investments - (1,628) - (1,478) (3,106)As at 31 March 2020 25,000 9,628 1,923 11,449 48,000 Investment in sukuks Quoted securities Unquoted Securities Units in quoted local real estate fund Total SR’000 SR’000 SR’000 SR’000 SR’000As at 1 January 2019 25,000 20,712 1,923 10,099 57,734 Purchases - 10,218 - - 10,218Disposals - (21,578) - - (21,578)Changes in fair value of investments - 1,904 - 2,828 4,732 As at 31 December 2019 25,000 11,256 1,923 12,927 51,106 | 7 |
| Disclosure of premiums/ contributions and insurance/ reinsurance or takaful/ retakaful balance receivables [text block] | 4. PREMIUMS AND REINSURERS’ RECEIVABLE - NET Receivables comprise amounts due from the following: 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Due from policyholders 88,764 74,438Due from policyholders – related parties 2,227 2,248Due from brokers and agents 15,437 19,547Receivables from reinsurers 6,392 4,984 112,820 101,217Provision for doubtful debts (6,491) (13,077)Premiums and reinsurers’ receivable – net 106,329 88,140 6. PREMIUMS AND REINSURERS’ RECEIVABLE - NET –(CONTINUED)Movement in provision for doubtful debts during the period / year was as follows: 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Balance at the beginning of the period / year 13,077 13,304Reversal for the period / year (6,586) (227)Balance at the end of the period / year 6,491 13,077 | 6 |
| Disclosure of cash and cash equivalents [text block] | 4. CASH AND CASH EQUIVALENTS Cash and cash equivalents included in the statement of cash flows comprise the following: 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Insurance operations Bank balances and cash 47,586 65,320Deposits maturing within 3 months from the acquisition date 140,483 - 188,069 65,320 Shareholders’ operations Bank balances and cash 14,825 12,159Deposits maturing within 3 months from the acquisition date * 56,101 - 70,926 12,159 These deposits earn commission at an average rate of 0.65% per annum as at 31 March 2020 (31 December 2019: nil).5. TERM DEPOSITS 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Insurance Operations Term deposits - 138,920Shareholders’ Operations Term deposits 55,663The term deposits are held with the commercial banks. These term deposits are denominated in Saudi Arabian Riyals and have been an original maturity of more than three months and less than twelve months. The carrying amounts of these term deposits reasonably approximate their fair values at the reporting date. | 4 |
| Disclosure of statutory deposit [text block] | 12. STATUTORY DEPOSIT 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Shareholders’ operations Statutory deposit 30,000 30,000As required by Saudi Arabian Insurance Regulations, the Company deposited 15% (31 December 2019: 15%) of its paid up capital, amounting to SR 30 million in a bank designated by the Saudi Arabian Monetary Authority (SAMA). The Company cannot withdraw this deposit without SAMA’s approval and commission accruing on this deposit is payable to SAMA. | 12 |
| Disclosure of gross unearned premiums/ contributions [text block] | Movement in unearned premiumsMovement in unearned premiums comprise of the following: For the period ended 31 March 2020 (Unaudited) Gross Reinsurance Net SR’000 SR’000 SR’000Balance as at the beginning of the period 254,360 (21,323) 233,037Premium written during the period 133,996 (20,463) 113,533Premium earned during the period (130,541) 14,187 (116,354)Balance as at the end of the period 257,815 (27,599) 230,216 For the year ended 31 December 2019 (Audited) Gross Reinsurance Net SR’000 SR’000 SR’000Balance as at the beginning of the year 252,007 (22,738) 229,269Premium written during the year 529,352 (58,485) 470,867Premium earned during the year (526,999) 59,900 (467,099)Balance as at the end of the year 254,360 (21,323) 233,037 | 8 |
| Disclosure of gross outstanding claims/ benefits [text block] | Net outstanding claims and reservesNet outstanding claims and reserves comprise of the following: 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Claims payable to policyholders Gross outstanding claims 28,621 34,024 28,621 34,024 Claims incurred but not reported 60,756 61,887Additional premium deficiency reserves 2,332 2,308Other technical reserves 1,486 1,716 93,195 99,935Less: - Reinsurers’ share of outstanding claims (10,860) (9,718)- Reinsurers’ share of claims incurred but not reported (7,246) (6,597) (18,106) (16,315)Net outstanding claims and reserves 75,089 83,620 | 8 |
| Disclosure of accrued expenses and other liabilities [text block] | 11. ACCRUED AND OTHER PAYABLES 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Accrued expenses 1,839 1,561Other payable 8,011 5,675Brokers payable 3,655 2,922VAT payable - 187 13,505 10,345 | 11 |
| Disclosure of zakat [text block] | 14. ZAKAT AND INCOME TAX 31 March 2020 31 December 2019 (Unaudited) (Audited) SR’000 SR’000Balance at the beginning of the period / year 8,479 5,086Provided during the period / year 648 3,393Payments during the period / year - -Balance at the end of the period / year 9,127 8,479The differences between the financial and the zakatable results are mainly due to certain adjustments in accordance with the relevant fiscal regulations.Zakat base has been computed based on the Company’s understanding of the Zakat regulations enforced in the Kingdom of Saudi Arabia. The Zakat regulations in Saudi Arabia are subject to different interpretations, and the assessments to be raised by the GAZT could be different from the declarations filed by the Company .Status of assessmentsZakat and income tax returns have been filed with the General Authority of Zakat and Tax (“GAZT”) for the years ended up to 31 December 2018. Final certificate has been received from GAZT for the year ended 31 December 2008. However, GAZT has raised an additional assessment in respect of the returns filed for the years ended 31 December 2008, 2009 and 2010 amounting to SR 1.86 million which has been paid. The major difference of additional assessment relates to disallowance of a portion of pre incorporation expenses and withholding tax. The Company has filed an objection against this additional assessment with the preliminary tax objection Committee subsequent to the year end, as adverse decision was received from the preliminary Tax Objection Committee, upon which the Company filed appeal with the Higher Objection Committee. The high appeal committee issued its decision in favour of the Company with respect to Zakat and rejected the appeal related to withholding tax. The Company has referred the matter to the board of grievance. In this regard, the Company has issued a letter of guarantee amounting to SAR 1.83 million in favour of GAZT (see contingency and commitment notes). And they have paid the amount of tax SAR 1,274,012. The company has raised an objection for unfavourable assessment raised by GAZT for the years 31 December 2013 till 2015 with the amount of SAR 4,981,048. The objection is currently under study by GAZTIncome tax:Foreign shareholder, being Islamic Development Bank (IDB) is exempted from income tax. | 15 |
| Disclosure of classes of share capital [text block] | 16. SHARE CAPITAL The authorized, issued and paid up capital of the Company was SAR 200 Million at 31 March 2020 (31 December 2019: SAR 200 Million) consisting of 20 Million shares On 16 January 2020, the Company’s board of directors approved the decrease in share capital amounting to SAR 59 million in order to absorb the accumulated losses and also approved to increase the share capital by SAR 150 million through the issuance of right shares to the existing shareholders. The Capital decrease has been approved by SAMA on 15 March 2020. Subsequent to the period end on 15 May 2020, Capital Market authority has also approved the said capital decrease. | 16 |
| Disclosure of earnings per share [text block] | 17. BASIC AND DILUTED EARNINGS PER SHAREEarnings per share for the period have been calculated by dividing the net income for the period by the weighted average number of issued and outstanding shares for the period. | 17 |
| Disclosure of related party transactions [text block] |
RELATED PARTY TRANSACTIONS AND BALANCES
Related parties represent major shareholders, directors and key management personnel of the Company, and companies of which they are principal owners and any other entities controlled, jointly controlled or significantly influenced by them. Pricing policies and terms of these transactions are approved by the Company’s management and Board of Directors. The following are the details of the major related party transactions during the period and the related balances:
Related party | Nature of transaction | Transactions for the three-months period ended | Closing balance Receivables / (Payables) |
|
| 31 March 2020 | 31 March 2019 | 31 March 2020 | 31 December 2019 |
|
| (Unaudited) | (Unaudited) | (Unaudited) | (Audited) |
|
| SR’000 | SR’000 | SR’000 | SR’000 | Abiat (Affiliate) | Premium written | - | 2 | 76 | 77 |
| Claim paid | (12) | (14) | - | (1) | Fuji Saudi Arabia (Affiliate) | Premium written | - | 28 | 1,047 | 1,048 |
| Claim paid | (210) | (291) | (10) | (100) | GEEC (Affiliate) | Premium written | - | 127 | 570 | 570 |
| Claim paid | (72) | (97) | (12) | (36) | Mayar Holding (Affiliate) | Premium written | (5) | - | 171 | 177 |
| Claim paid | (45) | 23 | (1) | (1) | Taya Feed Mill Factory (Affiliate | Premium written | - | 35 | 131 | 131 |
| Claim paid | (36) | (13) | - | (16) | Taya Real Estate (Affiliate) | Premium written | 11 | - | 12 | 3 |
| Claim paid | (48) | 23 | (1) | (15) | Taya Holding (Affiliate) | Premium written | - | 27 | - | - |
| Claim paid | (38) | 37 | (27) | (37) | GCP Co. (Affiliate) | Premium written | - | 4 | 66 | 66 |
| Claim paid | (5) | 9 |
| (1) | Al Huda Charity Trust (Affiliate) | Premium written | - | 3 | - | - |
| Claim paid | (3) | 2 | (1) | (2) | Saudi Wings Co. (Affiliate) | Premium written | - | - | 2 | 3 |
| Claim paid | (3) | (468) | - | (1) | Taya Agriculture Co. (Affiliate) | Premium written | - | - | 35 | 35 |
| Claim paid | (21) | 39 | (1) | (4) |
RELATED PARTY TRANSACTIONS AND BALANCES – (continued)
Related party | Nature of transaction | Transactions for the three-months period ended | Closing balance Receivables / (Payables) |
|
| 31 March 2020 | 31 March 2019 | 31 March 2020 | 31 December 2019 |
|
| (Unaudited) | (Unaudited) | (Unaudited) | (Audited) |
|
| SR’000 | SR’000 | SR’000 | SR’000 | Bakri and sons Holding Co. (Affiliate) | Premium written | - | - | - | - |
| Claim paid | - | - | (879) | (200) | Saudi Drip Irrigation system Co. (Affiliate) | Premium written | - | - | - | - |
| Claim paid | (55) | (75) | (3) | (36) | Red Sea Marine Services Co. (Affiliate) | Premium written | 6 | - | 71 | 65 |
| Claim paid | - | 9 | - | - | Edama Co. | Premium written | (1) | 12 | - | - |
| Claim paid | - | - | - | - | M/S Gulf Elevators and Escalators Co. Ltd. | Premium written | - | - | - | - |
| Claim paid | 45 | - | - | - | Abdullah Al Rayes Est. (Affiliate) | Premium written | 25 | 15 | - | 20 |
| Claim paid | (1) | 8 | - | - | NAMA Real Estate Co | Premium written | - | 16 | - | 2 |
| Claim paid | (1) | - | - | - | M/s Valie Real Estate | Premium written | - | 1 | - | - |
| Claim paid | (1) | - | - | - | VEION | Premium written | - | - | 42 | 42 |
| Claim paid | 33 | - | (17) | - |
|
|
|
|
|
| ACIG Bahrain (Shareholder) | Claims paid on behalf of ACIG Bahrain | 1,760 | 2,391 | - | - |
|
|
|
|
|
| Board and audit committee | Meetings fee | 12 | 82 | - | - |
|
|
|
|
|
| Key management personnel | Short term benefits | 1,369 | 1,369 | - | - | Long term benefits | 102 | 101 | - | - |
| 14 |
| Disclosure of entity's operating segments [text block] |
SEGMENTAL INFORMATION
Operating segments are identified on the basis of internal reports about components of the Company that are regularly reviewed by the Company’s Board of Directors in their function as chief operating decision maker in order to allocate resources to the segments and to assess its performance.
Transactions between the operating segments are on normal commercial terms and conditions. The revenue from external parties reported to the Board is measured in a manner consistent with that in the income statement. Segment assets and liabilities comprise operating assets and liabilities.
Segment results do not include general and administrative expenses, provision for doubtful debts and other income.
Segment assets do not include cash and cash equivalents, investments, prepayments and other receivables, and property and equipment, net.
Segment liabilities do not include reinsurance payables, accrued expenses and other liabilities, due to shareholders’ operations and employees’ terminal benefits.
13. SEGMENTAL INFORMATION – (continued)
These unallocated assets and liabilities are not reported to chief operating decision maker under related segments and are monitored on a centralized basis.
The segment information provided to the Company’s Board of Directors for the reportable segments for the Company’s total assets and liabilities at 31 March 2020 and 31 December 2019, its total revenues, expenses, and net income for the period then ended, are as follows:
|
| As at 31 March 2020 (Unaudited) |
Operating segments | Medical | Motor | General Accident |
|
Others | Total - Insurance operations |
| Shareholders operations | Total |
| SR’000 | SR’000 | SR’000 |
| SR’000 | SR’000 |
| SR’000 | SR’000 | Assets |
|
|
|
|
|
|
|
|
| Cash and cash equivalents | - | - | - |
| - | 188,069 |
| 70,926 | 258,995 | | Term Deposits | - | - | - |
| - | - |
| - | - | | Premiums and reinsurers’ receivable - net | - | - | - |
| - | 106,329 |
| - | 106,329 | | Reinsurers’ share of unearned premiums | 11,385 | - | 5,229 |
| 10,985 | 27,599 |
| - | 27,599 | | Reinsurers’ share of outstanding claims | 5,056 | 2,869 | 2,370 |
| 565 | 10,860 |
| - | 10,860 | | Reinsurers’ share of claims Incurred but not reported | 5,701 | - | 668 |
| 877 | 7,246 |
| - | 7,246 | | Deferred policy acquisition costs | 3,216 | 8,628 | 791 |
| 579 | 13,214 |
| - | 13,214 | | Unallocated assets | - | - | - |
| - | 72,259 |
| 84,087 | 156,346 | | Total assets | 25,358 | 11,497 | 9,058 |
| 13,006 | 425,576 |
| 155,013 | 580,589 | |
|
|
|
|
|
|
|
|
|
| | Liabilities |
|
|
|
|
|
|
|
|
| | Policyholders claims payable | - | - | - |
| - | 10,670 |
| - | 10,670 | | Reinsurers' balances payable | - | - | - |
| - | 25,248 |
| - | 25,248 | | Unearned reinsurance commission | - | - | 537 |
| 1,188 | 1,725 |
| - | 1,725 | | Unearned premiums | 54,272 | 175,767 | 15,662 |
| 12,114 | 257,815 |
| - | 257,815 | | Premium deficiency reserves | 2,332 | - | - |
| - | 2,332 |
| - | 2,332 | | Other technical reserves | 181 | 1,082 | 183 |
| 40 | 1,486 |
| - | 1,486 | | Outstanding claims | 17,055 | 5,208 | 5,632 |
| 726 | 28,621 |
| - | 28,621 | | Claims incurred but not reported | 19,187 | 38,059 | 2,552 |
| 958 | 60,756 |
| - | 60,756 | | Unallocated liabilities and equity | - | - | - |
| - | 36,923 |
| 155,013 | 191,936 | | Total liabilities | 93,027 | 220,116 | 24,566 |
| 15,026 | 425,576 |
| 155,013 | 580,589 | |
SEGMENTAL INFORMATION - (continued)
|
| As at 31 December 2019 (Audited) |
Operating segments | Medical | Motor | General Accident |
|
Others | Total - Insurance operations |
| Shareholders operations |
| Total |
| SR’000 | SR’000 | SR’000 |
| SR’000 | SR’000 |
| SR’000 |
| SR’000 | Assets |
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents | - | - | - |
| - | 65,320 |
| 12,159 |
| 77,479 | Term Deposits | - | - | - |
| - | 138,920 |
| 55,663 |
| 194,583 | Premiums and reinsurers’ receivable - net | - | - | - |
| - | 88,140 |
| - |
| 88,140 | Reinsurers’ share of unearned premiums | 11,952 | - | 5,111 |
| 4,260 | 21,323 |
| - |
| 21,323 | Reinsurers’ share of outstanding claims | 4,640 | 2,869 | 1,731 |
| 478 | 9,718 |
| - |
| 9,718 | Reinsurers’ share of claims Incurred but not reported | 5,053 | - | 667 |
| 877 | 6,597 |
| - |
| 6,597 | Deferred policy acquisition costs | 4,407 | 8,478 | 733 |
| 539 | 14,157 |
| - |
| 14,157 | Unallocated assets | - | - | - |
| - | 63,863 |
| 86,970 |
| 150,833 | Total assets | 26,052 | 11,347 | 8,242 |
| 6,154 | 408,038 |
| 154,792 |
| 562,830 |
Policyholders claims payable | - | - | - |
| - | 1,506 |
| - |
| 1,506 | Reinsurers' balances payable | - | - | - |
| - | 16,470 |
| - |
| 16,470 | Unearned reinsurance commission | - | - | 450 |
| 889 | 1,339 |
| - |
| 1,339 | Unearned premiums | 56,922 | 177,232 | 15,023 |
| 5,183 | 254,360 |
| - |
| 254,360 | Premium deficiency reserves | 2,308 | - | - |
| - | 2,308 |
| - |
| 2,308 | Other technical reserves | 171 | 1,322 | 183 |
| 40 | 1,716 |
| - |
| 1,716 | Outstanding claims | 16,303 | 12,309 | 4,776 |
| 636 | 34,024 |
| - |
| 34,024 | Claims incurred but not reported | 17,790 | 40,587 | 2,552 |
| 958 | 61,887 |
| - |
| 61,887 | Unallocated liabilities and equity | - | - | - |
| - | 34,428 |
| 154,792 |
| 189,220 | Total liabilities | 93,494 | 231,450 | 22,984 |
| 7,706 | 408,038 |
| 154,792 |
| 562,830 |
SEGMENTAL INFORMATION - (continued)
| For the three-months period ended 31 March 2020 (Unaudited) |
Operating segments | Medical |
| Motor |
| General Accident |
| Others |
| Total |
| SR’000 |
| SR’000 |
| SR’000 |
| SR’000 |
| SR’000 | REVENUES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross premiums written | 31,393 |
| 85,931 |
| 4,560 |
| 12,112 |
| 133,996 | Less: Reinsurance premiums ceded |
|
|
|
|
|
|
|
|
| -Local | (648) |
| - |
| (62) |
| (458) |
| (1,168) | -Foreign | (5,829) |
| - |
| (1,585) |
| (10,914) |
| (18,328) | Excess of loss premiums |
|
|
|
|
|
|
|
|
| -Local | - |
| (153) |
| (466) |
| (47) |
| (666) | -Foreign | - |
| (230) |
| (2) |
| (69) |
| (301) | Net written premiums | 24,916 |
| 85,548 |
| 2,445 |
| 624 |
| 113,533 | Changes in net unearned premiums | 2,082 |
| 1,465 |
| (521) |
| (205) |
| 2,821 | Net premiums earned | 26,998 |
| 87,013 |
| 1,924 |
| 419 |
| 116,354 | Other Underwriting Income | - |
| 966 |
| - |
| - |
| 966 | Reinsurance Commission earned | - |
| - |
| 172 |
| 894 |
| 1,066 | TOTAL REVENUES | 26,998 |
| 87,979 |
| 2,096 |
| 1,313 |
| 118,386 |
|
|
|
|
|
|
|
|
|
| UNDERWRITING COSTS AND EXPENSES |
|
|
|
|
|
|
|
|
| Gross claims paid and loss adjustment expenses | 32,962 |
| 78,725 |
| 1,038 |
| - |
| 112,725 | Less: Reinsurers’ share of claims paid | (9,194) |
| - |
| (10) |
| - |
| (9,204) | Net claims paid | 23,768 |
| 78,725 |
| 1,028 |
| - |
| 103,521 | Changes in outstanding claims, net | 337 |
| (7,101) |
| 217 |
| 3 |
| (6,544) | Changes in claims incurred but not reported, net | 748 |
| (2,528) |
| - |
| - |
| (1,780) | Change in loss adjustment expenses | 11 |
| (241) |
| - |
| - |
| (230) | Net claims incurred | 24,864 |
| 68,855 |
| 1,245 |
| 3 |
| 94,967 | Changes in premium deficiency reserve | 23 |
| - |
| - |
| - |
| 23 | Policy acquisition costs | 2,339 |
| 4,641 |
| 205 |
| 415 |
| 7,600 | Other underwriting expenses | 175 |
| 963 |
| - |
| - |
| 1,138 | TOTAL UNDERWRITING COSTS AND EXPENSES | 27,401 |
| 74,459 |
| 1,450 |
| 418 |
| 103,728 |
|
|
|
|
|
|
|
|
|
| NET UNDERWRITING (LOSS)/ INCOME | (403) |
| 13,520 |
| 646 |
| 895 |
| 14,658 |
|
|
|
|
|
|
|
|
|
| OTHER OPERATING (EXPENSES)/ INCOME |
|
|
|
|
|
|
|
|
| Release of doubtful debts |
|
|
|
|
|
|
|
| 6,491 | General and administrative expenses |
|
|
|
|
|
|
|
| (19,495) | Commission income on deposits |
|
|
|
|
|
|
|
| 1,091 | Realized gain on available-for-sale investments |
|
|
|
|
|
|
|
| 448 | Other income |
|
|
|
|
|
|
|
| 1 | TOTAL OTHER OPERATING (EXPENSES) / INCOME |
|
|
|
|
|
|
|
| (11,464) |
|
|
|
|
|
|
|
|
|
| NET SURPLUS |
|
|
|
|
|
|
|
| 3,194 | Surplus transferred to Shareholders |
|
|
|
|
|
|
|
| (2,877) | NET RESULT AFTER TRANSFER OF SURPLUS TO SHAREHOLDERS |
|
|
|
|
|
|
|
| 317 |
SEGMENTAL INFORMATION - (continued)
| For the three-months period ended 31 March 2019 (Unaudited) |
Operating segments | Medical |
| Motor |
| General Accident |
| Others |
| Total |
| SR’000 |
| SR’000 |
| SR’000 |
| SR’000 |
| SR’000 |
|
|
|
|
|
|
|
|
|
| REVENUES |
|
|
|
|
|
|
|
|
| Gross premiums written | 34,738 |
| 97,585 |
| 3,384 |
| 8,686 |
| 144,393 | Less: Reinsurance premiums ceded |
|
|
|
|
|
|
|
|
| -Local | (679) |
| - |
| (75) |
| (517) |
| (1,271) | - Foreign | (5,904) |
| - |
| (1,744) |
| (7,297) |
| (14,945) | Excess of loss premiums |
|
|
|
|
|
|
|
|
| -Local | - |
| (525) |
| (198) |
| (53) |
| (776) | - Foreign | - |
| (787) |
| (8) |
| (79) |
| (874) | Net written premiums | 28,155 |
| 96,273 |
| 1,360 |
| 739 |
| 126,527 | Changes in net unearned premiums | 4,593 |
| (14,304) |
| 764 |
| (371) |
| (9,318) | Net premiums earned | 32,748 |
| 81,969 |
| 2,124 |
| 368 |
| 117,209 | Other Underwriting Income | - |
| 421 |
| - |
| - |
| 421 | Reinsurance Commission earned | - |
| 4 |
| 153 |
| 718 |
| 875 | TOTAL REVENUES | 32,748 |
| 82,394 |
| 2,277 |
| 1,086 |
| 118,505 |
|
|
|
|
|
|
|
|
|
| UNDERWRITING COSTS AND EXPENSES |
|
|
|
|
|
|
|
|
| Gross claims paid and loss adjustment expenses | 33,033 |
| 60,459 |
| 119 |
| 75 |
| 93,686 | Less: Reinsurers’ share of claims paid | (7,934) |
| (1,575) |
| (58) |
| (60) |
| (9,627) | Net claims paid | 25,099 |
| 58,884 |
| 61 |
| 15 |
| 84,059 | Changes in outstanding claims, net | 1,796 |
| 3,585 |
| 112 |
| 136 |
| 5,629 | Changes in claims incurred but not reported, net | 1,487 |
| (2,261) |
| - |
| - |
| (774) | Change in loss adjustment expenses | 21 |
| 20 |
| - |
| - |
| 41 | Net claims incurred | 28,403 |
| 60,228 |
| 173 |
| 151 |
| 88,955 | Changes in premium deficiency reserve | (40) |
| - |
| - |
| - |
| (40) | Other technical reserves | - |
| - |
| - |
| - |
| - | Policy acquisition costs | 2,669 |
| 3,865 |
| 235 |
| 256 |
| 7,025 | Other underwriting expenses | 390 |
| 1,208 |
| - |
| - |
| 1,598 | TOTAL UNDERWRITING COSTS AND EXPENSES | 31,422 |
| 65,301 |
| 408 |
| 407 |
| 97,538 |
|
|
|
|
|
|
|
|
|
| NET UNDERWRITING (LOSS) / INCOME | 1,326 |
| 17,093 |
| 1,869 |
| 679 |
| 20,967 |
|
|
|
|
|
|
|
|
|
| OTHER OPERATING (EXPENSES) / INCOME |
|
|
|
|
|
|
|
|
| Allowance for doubtful debts |
|
|
|
|
|
|
|
| (118) | General and administrative expenses |
|
|
|
|
|
|
|
| (20,540) | Commission income on deposits |
|
|
|
|
|
|
|
| 1,522 | Realized gain on available-for-sale investments |
|
|
|
|
|
|
|
| 346 | TOTAL OTHER OPERATING (EXPENSES) / INCOME |
|
|
|
|
|
|
|
| (18,790) |
|
|
|
|
|
|
|
|
|
| NET SURPLUS |
|
|
|
|
|
|
|
| 2,177 | Surplus transferred to Shareholders |
|
|
|
|
|
|
|
| (1,979) | NET RESULT AFTER TRANSFER OF SURPLUS TO SHAREHOLDERS |
|
|
|
|
|
|
|
| 198 |
SEGMENTAL INFORMATION - (continued)
| For the three-months ended 31 March 2020 (Unaudited) |
| Medical | Motor | Properties and accident | Protection and savings | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | Gross written premium |
|
|
|
|
| Retail | 2,686 | 84,923 | 2,223 | - | 89,832 | Micro | 5,998 | 337 | - | - | 6,335 | Small | 13,372 | 930 | 647 | - | 14,949 | Medium | 4,993 | 212 | 2,118 | - | 7,323 | Large | 4,344 | (471) | 11,684 | - | 15,557 | Total | 31,393 | 85,931 | 16,672 | - | 133,996 |
| For the three-months period ended 31 March 2019 (Unaudited) |
| Medical | Motor | Properties and accident | Protection and savings | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | Gross written premium |
|
|
|
|
| Retail | 3,092 | 94,230 | 1,320 | - | 98,642 | Micro | 4,917 | 471 | 664 | - | 6,052 | Small | 10,107 | 1,069 | 3,040 | - | 14,216 | Medium | 4,478 | 1,059 | 661 | - | 6,198 | Large | 12,144 | 756 | 6,385 | - | 19,285 | Total | 34,738 | 97,585 | 12,070 | - | 144,393 |
| 13 |
| Disclosure of comparative figures [text block] | 19. COMPARATIVE FIGURESCertain prior period figures have been reclassified to conform to current period presentation (if applicable). | 19 |
| Disclosure of board of director's approval of the financial statements [text block] | 21. APPROVAL OF THE FINANCIAL STATEMENTSThese interim condensed financial statements have been approved by the Board of Directors on 11 June 2020 corresponding to 19 Shawwal 1441H. | 21 |
| Disclosure of other notes relevant to understanding of financial statements [text block] |
SUPPLEMENTARY INFORMATION
Statement of financial position
| 31 March 2020 (Unaudited) | 31 December 2019 (Audited) |
| Insurance operations | Shareholders’ operations | Total | Insurance operations | Share-holders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | ASSETS |
|
|
|
|
|
| Cash and cash equivalents | 188,069 | 70,926 | 258,995 | 65,320 | 12,159 | 77,479 | Term deposits | - | - | - | 138,920 | 55,663 | 194,583 | Premiums and reinsurers’ receivable – net | 106,329 | - | 106,329 | 88,140 | - | 88,140 | Reinsurers’ share of unearned premiums | 27,599 | - | 27,599 | 21,323 | - | 21,323 | Reinsurers’ share of outstanding claims | 10,860 | - | 10,860 | 9,718 | - | 9,718 | Reinsurers’ share of claims incurred but not reported | 7,246 | - | 7,246 | 6,597 | - | 6,597 | Deferred policy acquisition cost | 13,214 | - | 13,214 | 14,157 | - | 14,157 | Due from a related party | 1,985 | - | 1,985 | 1,760 | - | 1,760 | Property and equipment, net | 3,299 | - | 3,299 | 3,598 | - | 3,598 | Intangible assets | 4,974 | - | 4,974 | 5,008 | - | 5,008 | Right of use asset –net | 6,592 | - | 6,592 | 7,227 | - | 7,227 | Available-for-sale investments | - | 48,000 | 48,000 | - | 51,106 | 51,106 | Prepayments and other receivables | 55,409 | 4,368 | 59,777 | 46,270 | 4,211 | 50,481 | Statutory deposit | - | 30,000 | 30,000 | - | 30,000 | 30,000 | Accrued commission on statutory deposit | - | 1,719 | 1,719 | - | 1,653 | 1,653 | Total Assets | 425,576 | 155,013 | 580,589 | 408,038 | 154,792 | 562,830 |
|
|
|
|
|
|
| LIABILITIES |
|
|
|
|
|
| Policyholders claim payable | 10,670 | - | 10,670 | 1,506 | - | 1,506 | Accrued and other payables | 12,920 | 585 | 13,505 | 10,144 | 201 | 10,345 | Reinsurances’ balances payable | 25,248 | - | 25,248 | 16,470 | - | 16,470 | Unearned commission income | 1,725 | - | 1,725 | 1,339 | - | 1,339 | Unearned premiums | 257,815 | - | 257,815 | 254,360 | - | 254,360 | Premium deficiency reserve | 2,332 | - | 2,332 | 2,308 | - | 2,308 | Other technical reserve | 1,486 |
| 1,486 | 1,716 | - | 1,716 | Outstanding claims | 28,621 | - | 28,621 | 34,024 | - | 34,024 | Claims incurred but not reported | 60,756 | - | 60,756 | 61,887 | - | 61,887 | Employees’ terminal benefits | 12,472 | - | 12,472 | 12,011 | - | 12,011 | Lease liabilities | 6,063 | - | 6,063 | 7,122 | - | 7,122 | Surplus distribution payable | 6,299 | - | 6,299 | 5,982 | - | 5,982 | Accrued zakat and income tax | - | 9,127 | 9,127 | - | 8,479 | 8,479 | Accrued commission on statutory deposit payable to SAMA | - | 1,719 | 1,719 | - | 1,653 | 1,653 |
|
|
|
|
|
|
| TOTAL LIABILITIES | 426,407 | 11,431 | 437,838 | 408,869 | 10,333 | 419,202 |
|
|
|
|
|
|
| SHAREHOLDER’S EQUITY |
|
|
|
|
|
| Share capital | - | 200,000 | 200,000 | - | 200,000 | 200,000 | Accumulated losses | - | (57,285) | (57,285) | - | (59,514) | (59,514) | Fair value reserve on investments | - | 867 | 867 | - | 3,973 | 3,973 | TOTAL SHAREHOLDER’S EQUITY | - | 143,582 | 143,582 | - | 144,459 | 144,459 | Re-measurement reserve of employees’ terminal benefits | (831) | - | (831) | (831) | - | (831) | TOTAL EQUITY | (831) | 143,582 | 142,751 | (831) | 144,459 | 143,628 | TOTAL LIABILITIES AND EQUITY | 425,576 | 155,013 | 580,589 | 408,038 | 154,792 | 562,830 |
SUPPLEMENTARY INFORMATION – (continued)
Statement of income
| For the three-months period ended | For the three-months period ended |
| 31 March 2020 (Unaudited) | 31 March 2019 (Unaudited) (Restated) |
| Insurance operations | Shareholders’ operations | Total | Insurance operations | Shareholders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | REVENUES |
|
|
|
|
|
| Gross premiums written | 133,996 | - | 133,996 | 144,393 | - | 144,393 | Less: Reinsurance premiums ceded |
|
|
|
|
|
| Local | (1,168) | - | (1,168) | (1,271) | - | (1,271) | Foreign | (18,328) | - | (18,328) | (14,945) | - | (14,945) |
| (19,496) | - | (19,496) | (16,216) | - | (16,216) | Less: excess of loss premiums |
|
|
|
|
|
| Local | (666) | - | (666) | (776) | - | (776) | Foreign | (301) | - | (301) | (874) | - | (874) |
| (967) | - | (967) | (1,650) | - | (1,650) | Net premiums written | 113,533 | - | 113,533 | 126,527 | - | 126,527 | Changes in unearned premiums, net | 2,821 | - | 2,821 | (9,318) | - | (9,318) | Net premiums earned | 116,354 | - | 116,354 | 117,209 | - | 117,209 | Reinsurance commission earned | 1,066 | - | 1,066 | 875 | - | 875 | Other underwriting income | 966 | - | 966 | 421 | - | 421 | Net Revenues | 118,386 | - | 118,386 | 118,505 | - | 118,505 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross claims paid | 112,725 | - | 112,725 | 93,686 | - | 93,686 | Less: Reinsurers’ share of claims paid | (9,204) | - | (9,204) | (9,627) | - | (9,627) | Net claims paid | 103,521 | - | 103,521 | 84,059 | - | 84,059 | Changes in outstanding claims, net | (6,544) | - | (6,544) | 5,629 | - | 5,629 | Changes in incurred but not reported, net | (1,780) | - | (1,780) | (774) | - | (774) | Changes in loss adjustment expenses | (230) | - | (230) | 41 | - | 41 | Net claims incurred | 94,967 |
| 94,967 | 88,955 | - | 88,955 | Change in premium deficiency reserve | 23 | - | 23 | (40) | - | (40) | Policy acquisition costs | 7,600 | - | 7,600 | 7,025 | - | 7,025 | Other underwriting expenses | 1,138 | - | 1,138 | 1,598 | - | 1,598 | Total underwriting cost and expenses | 103,728 | - | 103,728 | 97,538 | - | 97,538 |
|
|
|
|
|
|
| Net result of insurance operations | 14,658 | - | 14,658 | 20,967 | - | 20,967 |
|
|
|
|
|
|
| OTHER OPERATING (EXPENSE) / INCOME |
|
|
|
|
|
| Release of / (allowance for) doubtful debts | 6,491 | - | 6,491 | (118) | - | (118) | General and administrative expenses | (18,882) | (613) | (19,495) | (20,048) | (492) | (20,540) | Commission income on deposits | 902 | 189 | 1,091 |
|
|
| Realized gain on available-for-sale investments | - | 448 | 448 | - | 346 | 346 | Investment income | - | - | - | 1,184 | 338 | 1,522 | Other income | 1 | - | 1 | - | - | - | TOTAL OTHER OPERATING (EXPENSES) / INCOME | (11,488) | 24 | (11,464) | (18,982) | 192 | (18,790) | Net Surplus | 3,170 | 24 | 3,194 | 1,985 | 192 | 2,177 | Surplus transferred to Shareholders | (2,853) | 2,853 | - | (1,787) | 1,787 | - | Net result after transfer of surplus to shareholders | 317 | 2,877 | 3,194 | 198 | 1,979 | 2,177 |
SUPPLEMENTARY INFORMATION – (continued)
Statement of income - (continued)
| For the three-months period ended | For the three-months period ended |
| 31 March 2020 (Unaudited) | 31 March 2019 (Unaudited) (Restated) |
| Insurance operations | Shareholders’ operations | Total | Insurance operations | Shareholders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 |
|
|
|
|
|
|
| Zakat expense for the period | - | (648) | (648) | - | (983) | (983) | Net result after zakat | 317 | 2,229 | 2,546 | 198 | 996 | 1,194 |
|
|
|
|
|
|
| Earnings Per share | 0.02 | 0.11 | 0.13 | 0.01 | 0.05 | 0.06 |
|
|
|
|
|
|
| Other comprehensive income / (loss) |
|
|
|
|
|
|
Shareholder’s absorption of deficit/surplus | 317 | 2,229 | 2,546 | 198 | 996 | 1,194 | Items that will not be reclassified to statement of income in subsequent periods |
|
|
|
|
|
| -Actuarial gains / (losses) on employees’ terminal benefits | - | - | - | - | - | - |
|
|
|
|
|
|
| Items that are or may be reclassified to statements of income in subsequent period |
|
|
|
|
|
| - Available-for-sale investments: | - | - | - |
|
|
| - Net change in fair value | - | (3,106) | (3,106) | - | 1,900 | 1,900 | TOTAL COMPREHENSIVE (LOSS) / INCOME FOR THE PERIOD | 317 | (877) | (560) | 198 | 2,896 | 3,094 |
SUPPLEMENTARY INFORMATION – (continued)
Statement of cash flows
| For the three-months period ended | For the three-months period ended |
| 31 March 2020 (Unaudited) | 31 March 2019 (Unaudited) | |
| Insurance operations | Shareholders’ operations | Total | Insurance operations | Shareholders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
| Total income for the period | 317 | 2,877 | 3,194 | 198 | 1,979 | 2,177 |
|
|
|
|
|
|
| Adjustments for non-cash items: |
|
|
|
|
|
| Depreciation of property and equipment | 276 | - | 276 | 765 | - | 765 | Amortization of intangible assets | 240 | - | 240 | - | - | - | Provision for employees’ terminal benefits | 497 | - | 497 | 424 | - | 424 | (Reversal of) / allowance for doubtful debts | (6,586) | - | (6,586) | 118 | - | 118 | Realized gain on available-for-sale investment | - | - | - | - | (346) | (346) |
|
|
|
|
|
|
| Changes in operating assets and liabilities: |
|
|
|
|
|
| Premiums and reinsurers’ receivable | (11,603) | - | (11,603) | (13,297) | - | (13,297) | Reinsurers’ share of unearned premiums | (6,276) | - | (6,276) | (5,468) | - | (5,468) | Reinsurers’ share of outstanding claims | (1,142) | - | (1,142) | (1,267) | - | (1,267) | Due from related party | (225) | - | (225) | - | - | - | Reinsurers’ share of claims Incurred but not reported | (649) | - | (649) | (769) | - | (769) | Deferred policy acquisition costs | 943 | - | 943 | (247) | - | (247) | Prepayments and other receivables | (9,139) | (157) | (9,296) | (8,403) | (552) | (8,955) | Decrease of right of use assets | 635 | - | 635 | (9,305) | - | (9,305) | Decrease in lease liability | (1,059) | - | (1,059) | 8,650 | - | 8,650 | Policyholders claim payables | 9,164 | - | 9,164 | (2,649) | - | (2,649) | Reinsurers' balances payable | 8,778 | - | 8,778 | 7,391 | - | 7,391 | Unearned commission income | 386 | - | 386 | 626 | - | 626 | Unearned premiums | 3,455 | - | 3,455 | 14,786 | - | 14,786 | Outstanding claims | (5,403) | - | (5,403) | 6,894 | - | 6,894 | Claims incurred but not reported and other technical reserves | (1,337) | - | (1,337) | (4) | - | (4) | Accrued and other payables | 2,776 | 384 | 3,160 | 6,827 | 239 | 7,066 |
| (15,952) | 3,104 | (12,848) | 5,270 | 1,320 | 6,590 |
|
|
|
|
|
|
| End-of-service indemnities paid | (36) | - | (36) | (39) | - | (39) | Net cash (used in) / generated from operating activities | (15,988) | 3,104 | (12,884) | 5,231 | 1,320 | 6,551 |
|
|
|
|
|
|
| CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
|
|
| Additions in property and equipment | (117) | - | (117) | (75) | - | (75) | Additions in intangible assets | (206) | - | (206) | (875) | - | (875) | (Placement) / maturity of in term deposits | 138,920 | 55,663 | 194,583 | 4,440 | (7,452) | (3,012) | Purchase of available-for-sale investments | - |
| - | - | (1,723) | (1,723) | Proceed from property and equipment | 140 | - | 140 | - |
|
| Proceed from sale of available-for-sale investment | - | - | - |
| 3,528 | 3,528 | Net cash from / (used in) investing activities | 138,737 | 55,663 | 194,400 | 3,490 | (5,647) | (2,157) |
|
|
|
|
|
|
| Net change in cash and cash equivalents | 122,749 | 58,767 | 181,516 | 8,721 | (4,327) | 4,394 | Cash and cash equivalents, beginning of the period | 65,320 | 12,159 | 77,479 | 83,409 | 10,086 | 93,495 | Cash and cash equivalents, end of the period | 188,069 | 70,926 | 258,995 | 92,130 | 5,759 | 97,889 |
COMPARATIVE FIGURES
Certain prior period figures have been reclassified to conform to current period presentation (if applicable).
SUBSEQUENT EVENTS
Subsequent to the period end, the Company obtained CMA approval for ongoing process for capital decrease, for details refer to Note 16.
In response to the Covid-19 pandemic, SAMA issued a decree 189 (the “Decree”) dated 8 May 2020 to all insurance companies in the Kingdom of Saudi Arabia. Among various other matters relating to the insurance sector, the Decree instructs all the insurance companies to extend the period of validity of all existing retail motor insurance policies by two months as well as providing a two-month additional coverage for all new retail motor policies written within one month of this Decree and allowing insurance companies not to cancel the policy in the event the insured fails to pay the premiums. The management believes that such requirements of the Decree are a non-adjusting event and therefore the interim condensed financial information have not been adjusted.
| 18 |